Novel Strategies for Medical Management of Obesity: Mechanisms, Clinical Implications, and Societal Impacts: a report from the 25th annual Harvard Nutrition Obesity Symposium

Obesity is a chronic, relapsing disease with a multifactorial etiology. Over the past five years, obesity medicine has entered a new era with the advent of novel, game-changing pharmacotherapies that achieve weight loss exceeding 15-20%. Beyond weight loss, these powerful therapies offer additional benefits, such as cardiovascular improvements. These novel agents, such as GLP-1 receptor agonists (GLP-1RAs), work by reducing appetite, slowing gastric emptying, and increasing feelings of fullness….

via https://pubmed.ncbi.nlm.nih.gov/40550419/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1HYeX0emtvYgH07Wkz0a8n9otrdMd-JIklc_uo0I5vh1u9WMEy&fc=None&ff=20250625010805&v=2.18.0.post9+e462414